Seoul, Korea – April 05, 2024 – (SeaPRwire) – MVL, a blockchain mobility company, has recently announced a strategic partnership with IoTeX, a prominent player in the DePIN (Decentralized Physical Infrastructure Network) sector. This collaboration is set to enhance the utility and value of mobility Continue Reading

Seoul, Korea – April 05, 2024 – (SeaPRwire) – BF Labs announced that ‘BubbleFong Friends’ started its global Open Beta Test (OBT) from 28th March. ‘BubbleFong Friends’ is a classic arcade bubble shooter game where the Pinkfong Wonderstar characters pop bubbles together under the refreshing ocean. AsContinue Reading

Road Town, BVI – April 02, 2024 – (SeaPRwire) – BlackFort, an ecosystem featuring a multichain wallet, a payment solution, and an L1 blockchain, is pleased to announce that its $BXN token will make its debut on the BITFINEX exchange on April 2, 2024. BXN deposits are set to open at 10 am UTC, while Continue Reading

New York, NY – 03/29/2024 – (SeaPRwire) – WebWise Pad is an online platform that allows users to invest in promising projects during private rounds under exclusive conditions similar to those offered to venture funds, which are inaccessible to ordinary investors. The platform’s uniqueness lies in itContinue Reading

New York, NY – 03/29/2024 – (SeaPRwire) – Today, BitGrid (https://BitGrid.cloud) is proud to announce the launch of their new solutions of intelligent quantitative trading. With the rapid development of the digital asset market and the constantly changing trading environment, investors’ demand for mContinue Reading

Web3 Big Data + AI = Money: how RateX Network addresses Web3 scoring system challenges New York, NY – 03/29/2024 – (SeaPRwire) – RateX Network today announces their updated AI-Driven solutions for Web3 Scoring Systems, which are going to enhancing business capabilities and streamlining decision-makiContinue Reading

SHENZHEN, CHINA – 03/28/2024 – (SeaPRwire) – On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results. The Company recorded a turnover of RMB8,013 million, a year-on-year decrease of 12.4%; in the case that all medicines were directly sold by the Group, the tContinue Reading